Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats

Rebecka Holmberg, William Klitz, Martin Blixt, Per Olof Berggren, Lisa Juntti-Berggren, Bo Niklasson

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The effects of LV in two different species, CD-1 mice, without a genetic disposition for diabetes, and BB rats prone to T1D were examined. Male CD-1 mice that had been exposed toLV in utero developed a type 2-like diabetes with increased blood glucose, insulin levels and epididymal fat at the age of 10-15 weeks. Combination therapy including LV-antiserum and an antiviral drug, Pleconaril, significantly reduced the levels of blood glucose and insulin and the amount of abdominal fat. In BB rats, LV has been found in both prediabetic- and diabetic diabetes-prone rats, as well as in diabetes-resistant rats. To evaluate whether the presence of LV has any influence on the onset of T1D, prediabetic BB rats were treated with an antiserum against LV or a combination of the antiviral drugs Pleconaril and Ribavirin. In the group treated with antiviral drugs, the onset was significantly delayed. These results indicate that the presence of LV can be involved in the pathogenesis of diabetes in these animal models.

Original languageEnglish
Pages (from-to)567-572
Number of pages6
JournalMicrobiology and Immunology
Volume53
Issue number10
DOIs
StatePublished - Oct 1 2009
Externally publishedYes

Fingerprint

Parechovirus
Inbred BB Rats
Antiviral Agents
Blood Glucose
Immune Sera
Insulin
Abdominal Fat
Ribavirin
Type 2 Diabetes Mellitus
Animal Models
Fats
pleconaril
Therapeutics

Keywords

  • Antibody treatment
  • Antiviral therapy
  • Viral infection

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology

Cite this

Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats. / Holmberg, Rebecka; Klitz, William; Blixt, Martin; Berggren, Per Olof; Juntti-Berggren, Lisa; Niklasson, Bo.

In: Microbiology and Immunology, Vol. 53, No. 10, 01.10.2009, p. 567-572.

Research output: Contribution to journalArticle

Holmberg, Rebecka ; Klitz, William ; Blixt, Martin ; Berggren, Per Olof ; Juntti-Berggren, Lisa ; Niklasson, Bo. / Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats. In: Microbiology and Immunology. 2009 ; Vol. 53, No. 10. pp. 567-572.
@article{df0b0937bb494b80bd63da40947c06ee,
title = "Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats",
abstract = "The effects of LV in two different species, CD-1 mice, without a genetic disposition for diabetes, and BB rats prone to T1D were examined. Male CD-1 mice that had been exposed toLV in utero developed a type 2-like diabetes with increased blood glucose, insulin levels and epididymal fat at the age of 10-15 weeks. Combination therapy including LV-antiserum and an antiviral drug, Pleconaril, significantly reduced the levels of blood glucose and insulin and the amount of abdominal fat. In BB rats, LV has been found in both prediabetic- and diabetic diabetes-prone rats, as well as in diabetes-resistant rats. To evaluate whether the presence of LV has any influence on the onset of T1D, prediabetic BB rats were treated with an antiserum against LV or a combination of the antiviral drugs Pleconaril and Ribavirin. In the group treated with antiviral drugs, the onset was significantly delayed. These results indicate that the presence of LV can be involved in the pathogenesis of diabetes in these animal models.",
keywords = "Antibody treatment, Antiviral therapy, Viral infection",
author = "Rebecka Holmberg and William Klitz and Martin Blixt and Berggren, {Per Olof} and Lisa Juntti-Berggren and Bo Niklasson",
year = "2009",
month = "10",
day = "1",
doi = "10.1111/j.1348-0421.2009.00160.x",
language = "English",
volume = "53",
pages = "567--572",
journal = "Microbiology and Immunology",
issn = "0385-5600",
publisher = "Center for Academic Publications Japan",
number = "10",

}

TY - JOUR

T1 - Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats

AU - Holmberg, Rebecka

AU - Klitz, William

AU - Blixt, Martin

AU - Berggren, Per Olof

AU - Juntti-Berggren, Lisa

AU - Niklasson, Bo

PY - 2009/10/1

Y1 - 2009/10/1

N2 - The effects of LV in two different species, CD-1 mice, without a genetic disposition for diabetes, and BB rats prone to T1D were examined. Male CD-1 mice that had been exposed toLV in utero developed a type 2-like diabetes with increased blood glucose, insulin levels and epididymal fat at the age of 10-15 weeks. Combination therapy including LV-antiserum and an antiviral drug, Pleconaril, significantly reduced the levels of blood glucose and insulin and the amount of abdominal fat. In BB rats, LV has been found in both prediabetic- and diabetic diabetes-prone rats, as well as in diabetes-resistant rats. To evaluate whether the presence of LV has any influence on the onset of T1D, prediabetic BB rats were treated with an antiserum against LV or a combination of the antiviral drugs Pleconaril and Ribavirin. In the group treated with antiviral drugs, the onset was significantly delayed. These results indicate that the presence of LV can be involved in the pathogenesis of diabetes in these animal models.

AB - The effects of LV in two different species, CD-1 mice, without a genetic disposition for diabetes, and BB rats prone to T1D were examined. Male CD-1 mice that had been exposed toLV in utero developed a type 2-like diabetes with increased blood glucose, insulin levels and epididymal fat at the age of 10-15 weeks. Combination therapy including LV-antiserum and an antiviral drug, Pleconaril, significantly reduced the levels of blood glucose and insulin and the amount of abdominal fat. In BB rats, LV has been found in both prediabetic- and diabetic diabetes-prone rats, as well as in diabetes-resistant rats. To evaluate whether the presence of LV has any influence on the onset of T1D, prediabetic BB rats were treated with an antiserum against LV or a combination of the antiviral drugs Pleconaril and Ribavirin. In the group treated with antiviral drugs, the onset was significantly delayed. These results indicate that the presence of LV can be involved in the pathogenesis of diabetes in these animal models.

KW - Antibody treatment

KW - Antiviral therapy

KW - Viral infection

UR - http://www.scopus.com/inward/record.url?scp=73349083391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73349083391&partnerID=8YFLogxK

U2 - 10.1111/j.1348-0421.2009.00160.x

DO - 10.1111/j.1348-0421.2009.00160.x

M3 - Article

C2 - 19780970

AN - SCOPUS:73349083391

VL - 53

SP - 567

EP - 572

JO - Microbiology and Immunology

JF - Microbiology and Immunology

SN - 0385-5600

IS - 10

ER -